QQQ $ 486.52 $ 5.06 (1.05 %)
DIA $ 393.25 $ 1.83 (0.47 %)
SPY $ 548.30 $ 3.67 (0.67 %)
TLT $ 90.61 $ 0.70 (0.78 %)
GLD $ 215.57 $ -0.01 (0 %)
$ 0.0007
-- x --
-- x --
-- - --
$ 0.00 - $ 0.05
560,000
na
45,131
$ -2.10
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-20-2023 09-30-2023 10-Q
2 08-21-2023 06-30-2023 10-Q
3 05-18-2023 03-31-2023 10-Q
4 04-17-2023 12-31-2022 10-K
5 11-21-2022 09-30-2022 10-Q
6 08-22-2022 06-30-2022 10-Q
7 05-12-2022 03-31-2022 10-Q
8 04-15-2022 12-31-2021 10-K
9 11-15-2021 09-30-2021 10-Q
10 08-19-2021 06-30-2021 10-Q
11 05-17-2021 03-31-2021 10-Q
12 04-15-2021 12-31-2020 10-K
13 11-03-2020 10-31-2020 10-Q
14 10-01-2020 07-31-2020 10-Q
15 07-27-2020 04-30-2020 10-Q
16 07-09-2020 01-31-2020 10-K
17 03-05-2020 10-31-2019 10-Q
18 10-18-2019 07-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 who-is-who-in-cannabis-latest-industry-appointments-you-should-know-about

Washington Cannabis Regulator Onboards New Director With 30 Years Of Cannabis Experience

 acquisition-of-this-cbd-gummy-manufacturer-could-position-bloomios-to-uplist-to-nasdaq

Bloomios, Inc. (OTCQB: BLMS), has acquired Infusionz, a wholly-owned subsidiary of Upexi Inc. (NASDAQ: UPXI).

 bloomios-to-manufacture-dryworlds-new-athletic-performance-cbd-product-line

Bloomios, Inc.